Catalent Inc
NYSE:CTLT

Watchlist Manager
Catalent Inc Logo
Catalent Inc
NYSE:CTLT
Watchlist
Price: 55.37 USD 0.2% Market Closed
Updated: May 19, 2024

Catalent Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Catalent Inc
Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Catalent Inc
NYSE:CTLT
Cash Equivalents
$162m
CAGR 3-Years
-45%
CAGR 5-Years
-7%
CAGR 10-Years
11%
Johnson & Johnson
NYSE:JNJ
Cash Equivalents
$3.8B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
-15%
Bristol-Myers Squibb Co
NYSE:BMY
Cash Equivalents
$9.3B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Cash Equivalents
$719m
CAGR 3-Years
-26%
CAGR 5-Years
-18%
CAGR 10-Years
-13%
Merck & Co Inc
NYSE:MRK
Cash Equivalents
$5.6B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Cash Equivalents
$2.5B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
-4%

See Also

What is Catalent Inc's Cash Equivalents?
Cash Equivalents
162m USD

Based on the financial report for Mar 31, 2024, Catalent Inc's Cash Equivalents amounts to 162m USD.

What is Catalent Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
11%

Over the last year, the Cash Equivalents growth was -36%. The average annual Cash Equivalents growth rates for Catalent Inc have been -45% over the past three years , -7% over the past five years , and 11% over the past ten years .